SMTL ID : 3o96.1

Crystal Structure of Human AKT1 with an Allosteric Inhibitor

Coordinates

PDB Format Compare

Method

X-RAY DIFFRACTION 2.70 Å

Oligo State

monomer

Ligands

1 x IQO: 1-(1-(4-(7-phenyl-1H-imidazo[4,5-g]quinoxalin-6-yl)benzyl)piperidin-4-yl)-1H-benzo[d]imidazol-2(3H)-one(Non-covalent)

IQO.1: 18 residues within 4Å: Chain A: W.83, T.85, V.86, I.87, E.88, S.208, L.213, T.214, L.267, K.271, V.274, Y.275, R.276, D.277, I.293, T.294, D.295, C.299 12 PLIP interactions: 12 interactions with chain A Hydrophobic interactions: A:I.87, A:L.213, A:L.267, A:K.271, A:Y.275, A:D.295 Hydrogen bonds: A:S.208, A:K.271 Water bridges: A:N.57 pi-Stacking: A:W.83, A:W.83, A:W.83

Links

RCSB   PDBe   PDBe-KB   PDBj   PDBsum   CATH   PLIP

Citation

Wu, W.I. et al., Crystal structure of human AKT1 with an allosteric inhibitor reveals a new mode of kinase inhibition. Plos One (2010)

Release Date

2010-10-13

Peptides

RAC-alpha serine/threonine-protein kinase: A

SMTL:PDB

SMTL Chain Id:
PDB Chain Id:

A
A

RAC-alpha serine/threonine-protein kinase